Page 26 - Compass Pathways News Today

The Psychedelic House of Davos, a satellite event happening in conjunction with the World Economic Forum, was a ‘genius strategy’ to build credibility, say experts

INmune Bio's XPro is probably the most-promising drug candidate in the history of neurodegenerative diseases. Read about INMB stock here.

Investegate announcements from COMPASS Pathways, COMPASS Pathways presents largest ever study of psilocybin therapy, at American Psychiatric Association annual meeting

Positive data from phase IIb study shows potential of COMP360 psilocybin therapy in treatment-resistant depression London, UK – 23 May...

/PRNewswire/ -- As world leaders come together to discuss the global economy at the World Economic Forums annual gathering, the worlds most prominent...

Decades of biological research haven't improved diagnosis or treatment. We should look to society, not to the brain.

The best uncensored news, information, and analysis.

The psychedelics industry is quickly becoming the latest playground for celebrity investors and influencers in the financial sphere. Kevin Harrin...

Psychedelics policy action took center stage this week.  In Connecticut, the House of Representatives approved a budget bill that ...

How did the former governor become a leading advocate for psychedelics?